Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.22 USD | +1.26% | +1.58% | -16.41% |
Apr. 04 | Acumen Pharmaceuticals Signs Deal With Lonza to Manufacture Alzheimer's Treatment Drug | MT |
Apr. 04 | Lonza Enters Manufacturing Agreement for Acumen’s Alzheimer’s Disease Drug Candidate | MT |
- Stock Market
- Equities
- ABOS Stock
- News Acumen Pharmaceuticals, Inc.
- MarketScreener Strategies